A new family of PDE4 inhibitors based on a benzimidazole framework is described. Several of these compounds are orally bioavailable and show efficacy in in vivo models of inflammatory disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0960-894x(98)00497-1 | DOI Listing |
Publication Analysis
Top Keywords
pde4 inhibitors
8
2-substituted-4-methoxybenzimidazole-based pde4
4
inhibitors family
4
family pde4
4
inhibitors based
4
based benzimidazole
4
benzimidazole framework
4
framework described
4
described compounds
4
compounds orally
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!